Comprehensive analysis of CTLA-4 in the tumor immune microenvironment of 33 cancer types

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

Jedd D. Wolchok, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2017 · 5.3K citations · Full text

Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression

Étienne Becht, Nicolás A. Giraldo, Laetitia Lacroix et al. · Genome biology · 2016 · 3.9K citations · Full text

Olaparib for Metastatic Breast Cancer in Patients with a Germline <i>BRCA</i> Mutation

Mark E. Robson, Seock‐Ah Im, Elżbieta Senkus et al. · New England Journal of Medicine · 2017 · 3.1K citations · Full text

An immune-active tumor microenvironment favors clinical response to ipilimumab

Rui‐Ru Ji, Scott D. Chasalow, Lisu Wang et al. · Cancer Immunology Immunotherapy · 2011 · 775 citations · Full text

Immune Evasion, Tumor Immunology, Cancer Immunosurveillance +8

CS1, a Potential New Therapeutic Antibody Target for the Treatment of Multiple Myeloma

Eric D. Hsi, Roxanne Steinle, Balaji Balasa et al. · Clinical Cancer Research · 2008 · 555 citations · Full text